Pulmonx Corporation
LUNG
$3.42
$0.164.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.45M | -13.18M | -14.14M | -15.33M | -13.75M |
| Total Depreciation and Amortization | 278.00K | 294.00K | -424.00K | 1.20M | 423.00K |
| Total Amortization of Deferred Charges | 11.00K | 11.00K | 811.00K | 931.00K | 16.00K |
| Total Other Non-Cash Items | 5.72M | 5.35M | 5.69M | 6.11M | 6.14M |
| Change in Net Operating Assets | -4.78M | 789.00K | 825.00K | 1.31M | -4.63M |
| Cash from Operations | -13.22M | -6.73M | -7.24M | -5.77M | -11.80M |
| Capital Expenditure | -301.00K | -111.00K | -416.00K | -469.00K | -451.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.61M | 14.18M | 7.17M | -366.00K | -2.06M |
| Cash from Investing | 16.31M | 14.07M | 6.75M | -835.00K | -2.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -49.00K | 0.00 | -46.00K | -- |
| Issuance of Common Stock | 664.00K | 111.00K | 459.00K | 24.00K | 864.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 664.00K | 62.00K | 459.00K | -22.00K | 864.00K |
| Foreign Exchange rate Adjustments | -105.00K | 193.00K | -119.00K | -46.00K | 48.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.65M | 7.59M | -151.00K | -6.67M | -13.39M |